Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery

被引:73
作者
Al-Shawaf, Emad
Ayed, Adel
Vislocky, Ivan
Radomir, Bosko
Dehrab, Najat
Tarazi, Riad
机构
[1] Minist Hlth, Chest Dis Hosp, Dept Anesthesia, Safat, Kuwait
[2] Minist Hlth, Chest Dis Hosp, Dept Cardiothorac Surg, Safat, Kuwait
关键词
diabetic; low ejection fraction; coronary artery bypass graft surgery; low-output syndrome; levosimendan; milrinone;
D O I
10.1053/j.jvca.2006.02.012
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: The purpose of this study was to compare the hemodynamic profiles and the postoperative insulin requirements in 2 groups of type 2 diabetic patients with depressed myocardial function who underwent elective surgery for coronary artery disease and who received levosimendan or milrinone for postcardiopulmonary bypass low-output syndrome. Design: Randomized controlled trial. Setting: The Chest Diseases Hospital, Safat, Kuwait. Participants: Type 2 diabetic patients undergoing elective surgery for coronary artery disease. Interventions: Fourteen patients and 16 patients received levosimendan and milrinone infusions, respectively, for treatment of the low-output syndrome. Measurements and Main Results: The hemodynamic, mixed venous oxygen saturation, oxygen extraction ratios, arterial lactate concentrations, and postoperative insulin infusion rates were serially documented for the first 48 hours after the diagnosis. The cardiac index and mixed venous oxygen saturation were significantly higher in the levosimendan group. The pulmonary capillary wedge pressure, systemic vascular resistance, and oxygen extraction ratios were significantly higher in the milrinone treatment group. The insulin requirements were similar for both of the treatment groups. Conclusions: Levosimendan was more efficient than milrinone for treating the hemodynamic manifestations of the postcardiopulmonary bypass low-output syndrome. However, all the values in the milrinone treatment group were normalized. In this small population, both treatment groups had similar postoperative insulin requirements. (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 20 条
[1]   Levosimendan increases L-type Ca2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes [J].
Ajiro, Y ;
Hagiwara, N ;
Katsube, Y ;
Sperelakis, N ;
Kasanuki, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 435 (01) :27-33
[2]   Cardiac surgery in the octogenarian: Evaluation of risk, cost, and outcome [J].
Avery, GJ ;
Ley, SJ ;
Hill, RD ;
Hershon, JJ ;
Dick, SE .
ANNALS OF THORACIC SURGERY, 2001, 71 (02) :591-596
[3]  
Bowman P, 1999, J PHARMACOL EXP THER, V288, P316
[4]  
Chernov SA, 2002, TERAPEVT ARKH, V74, P45
[5]   Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial [J].
Follath, F ;
Cleland, JGF ;
Just, H ;
Papp, JGY ;
Scholz, H ;
Peuhkurinen, K ;
Harjola, VP ;
Mitrovic, V ;
Abdalla, M ;
Sandell, EP ;
Lehtonen, L .
LANCET, 2002, 360 (9328) :196-202
[6]   PHARMACOLOGY OF BIPYRIDINE PHOSPHODIESTERASE-III INHIBITORS [J].
HONERJAGER, P .
AMERICAN HEART JOURNAL, 1991, 121 (06) :1939-1944
[7]   ATP-SENSITIVE K+ CHANNEL IN THE MITOCHONDRIAL INNER MEMBRANE [J].
INOUE, I ;
NAGASE, H ;
KISHI, K ;
HIGUTI, T .
NATURE, 1991, 352 (6332) :244-247
[8]   Intracoronary levosimendan enhances contractile function of stunned myocardium [J].
Jamali, IN ;
Kersten, JR ;
Pagel, PS ;
Hettrick, DA ;
Warltier, DC .
ANESTHESIA AND ANALGESIA, 1997, 85 (01) :23-29
[9]   Diabetes and hyperglycemia impair activation of mitochondrial KATP channels [J].
Kersten, JR ;
Montgomery, MW ;
Ghassemi, T ;
Gross, ER ;
Toller, WG ;
Pagel, PS ;
Warltier, DC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 280 (04) :H1744-H1750
[10]  
Labriola C, 2004, INT J CLIN PHARM TH, V42, P204